Learn more about SKYRIZI® (risankizumab‐rzaa)
Get to know SKYRIZI, an FDA‐approved biologic treatment for adults with Ps, PsA, CD, & UC. See full Safety and Prescribing Information.
Skyrizi: Uses, Dosage, Side Effects and more Drugs.com
Nov 11, 2025 · Skyrizi (risankizumab) is a prescription medication used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease, which are chronic inflammatory diseases. …
SKYRIZI® (risankizumab-rzaa) HCP - Official Site by AbbVie Inc.
Plaque Psoriasis: SKYRIZI is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
Risankizumab - Wikipedia
Risankizumab is indicated for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. [3][6][7] In Japan, it is also indicated for the treatment of generalized pustular …
Skyrizi: Side effects, uses, dosage, cost, and more
Aug 8, 2025 · Skyrizi (risankizumab-rzaa) is a brand-name drug approved to treat plaque psoriasis, Crohn’s disease, and other conditions. Skyrizi works by reducing inflammation associated with these...
Skyrizi (Risankizumab-rzaa Injection): Side Effects, Uses ...
May 21, 2025 · Skyrizi (Risankizumab-rzaa Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …
Skyrizi (risankizumab-rzaa) - Uses, Side Effects, and More
Aug 21, 2024 · Find patient medical information for Skyrizi (risankizumab-rzaa) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Your Guide to Skyrizi for Psoriatic Arthritis - HealthCentral
Dec 29, 2025 · Skyrizi is used to treat adults with active psoriatic arthritis. It is also approved as a treatment for moderate to severe plaque psoriasis, moderate to severe Crohn’s disease and …
Skyrizi (Risankizumab): Uses & Side Effects - Cleveland Clinic
Skyrizi (risankizumab) treats symptoms of psoriasis, psoriatic arthritis and Crohn's disease by reducing inflammation in your body.
Label - Food and Drug Administration
SKYRIZI is indicated for the treatment of moderately to severely active Crohn's disease in adults. Evaluate patients for tuberculosis (TB) infection prior to initiating treatment with SKYRIZI...